Dutasteride/Avodart CAS 164656-23-9 For Treating Hair loss Without Side Effect

Dutasteride/Avodart CAS 164656-23-9 For Treating Hair loss Without Side Effect

Detalles Rápidos :

Dutasteride (Avodart)

Sinónimos en inglés: (5alfa,17beta)-norte-{2,5-Bis(trifluorometilo)fenilo}-3-oxo-4-azaandrost-l-ene-17-carboxamide;DUTASTERIDE;GG-745, GI-198745,;5α,17β)-NORTE-[2,5-Bis(trifluorometilo)fenilo]-3-oxo-4- Aza -androst-1-ene-17-carboxamide;Duagen;(5a,17)-NORTE-[2,5-Bis(trifluorometilo)fenilo]-3-oxo-4-azaandrost-1-ene-17-carboxamide;Avodart;GI 198745

CAS NO.: 164656-23-9

Ensayo: 99%

Fórmula molecular:C27H30F6N2O2

Peso molecular:528.53

Embalaje:1kg/tin/foil bag

Estándar: Enterprise/USP

Apariencia: Polvo cristalino blanco o casi blanco

Uso: Prostate enlargement, male pattern hair loss, seborrheic alopecia, hereditary hair loss

Solicitud:

This class of medications increases rates of erectile dysfunction (with between 5% Estanozolol semielaborado de la serie líquida de esteroides 9% developing problems after starting their use). This is linked to lower quality of life and can cause stress in relationships. There is also an association with lowered sexual desire. It has been reported that these adverse sexual side effects may persist even after discontinuation of the drug. The FDA has added a warning to dutasteride about an increased risk of high-grade prostate cancer.

While the potential for positive, negative or neutral changes to the potential risk of developing prostate cancer with dutasteride has not been established, evidence has suggested it may temporarily reduce the growth and prevalence of benign prostate tumors, but could also mask the early detection of prostate cancer.

Dutasteride /Avodart COA: